Clinical trial
Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With…
NCT00004488 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00004488 |
|---|---|
| Title | Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gaucher's Disease, Osteopenia |
| Intervention type | Drug |
| Interventions | alendronate sodium, calcium carbonate, cholecalciferol |
| Enrollment | 82 |
| Start date | Oct 1, 1998 |
| Completion | Sep 1, 2002 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
| Countries | Israel, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: